TrialHepatology international2025

Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial.

Meng-Tzu Weng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.